Tag: Heart / Stroke-Related: Coronary-Artery Disease
Rosuvastatin, Atorvastatin Have Comparable Efficacy for CAD
Comparable efficacy seen for composite outcome; rosuvastatin linked to lower LDL-cholesterol levels
High-Intensity Statins Underused With Atherosclerotic Cardiovascular Disease
Authors say findings show gaps between practice and guideline-based care
Food Additive Emulsifier Intake Linked to Risk for CVD
Higher intake of celluloses (E460 to E468) positively associated with higher risks for CVD and coronary heart disease
Upfront Combo Lipid-Lowering Therapy Best for Acute Coronary Syndrome
Combination approach better than statin monotherapy for all-cause mortality at one, three, and five years in acute coronary syndromes
Availability of CVD Meds Varies by Low-Cost Generic Program
Variation in coverage seen by program, drug, and cardiovascular disease condition
Aspirin Underused in Secondary Prevention of Cardiovascular Disease
Estimates of use increased from 16.6 percent in low-income countries to 65.0 percent in high-income countries
Heterogeneity Found in Appropriate Use Criteria for Imaging of CAD
CMS-qualified AUC for coronary artery disease heterogeneous, sometimes conflict with respect to appropriateness
Coronary Heart Disease Mortality Dropped From 1990 to 2019
Half of all CHD deaths could have been prevented with elimination of smoking, alcohol, and obesity
Recommendations Developed for Chronic Coronary Disease
Team-based, patient-centered care emphasized, which considers social determinants of care and linked costs
P2Y₁₂ Inhibitor Monotherapy Better Than Aspirin in Coronary Artery Disease
Reduced risk seen for composite of cardiovascular death, myocardial infarction, and stroke
